-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$12.001248.31% Upside
Verrica Pharmaceuticals Inc. Frequently Asked Questions
-
What analysts cover Verrica Pharmaceuticals Inc.?
Verrica Pharmaceuticals Inc. has been rated by research analysts at Jefferies, H.C. Wainwright, Needham in the past 90 days.